Genome-wide analysis of aberrant DNA methylation for identification of potential biomarkers in colorectal cancer patients

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 5, 2012, Pages 1917-1921

  Fang, Wei Jia ^a   Zheng, Yi ^a   Wu, Li Ming ^a   Ke, Qing Hong ^a   Shen, Hong ^b   Yuan, Ying ^b   Zheng, Shu Sen ^a  

^a BEIJING HOSPITAL   (China)

^b THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Bisulphite conversion method; Colorectal cancer; DNA methylation; Genome wide analysis

Indexed keywords

C2ORF40 PROTEIN, HUMAN; CHEMOKINE; CMTM2 PROTEIN, HUMAN; MARVEL DOMAIN CONTAINING PROTEIN; SH3GL3 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TUMOR MARKER; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CLUSTER ANALYSIS; COLON; COLORECTAL TUMOR; COMPARATIVE STUDY; DNA METHYLATION; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETICS; HUMAN; HUMAN GENOME; MALE; METABOLISM; PROGNOSIS; PROMOTER REGION; RECTUM; SENSITIVITY AND SPECIFICITY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; CASE-CONTROL STUDIES; CHEMOKINES; CLUSTER ANALYSIS; COLON; COLORECTAL NEOPLASMS; DNA METHYLATION; GENE EXPRESSION PROFILING; GENOME, HUMAN; HUMANS; MALE; MARVEL DOMAIN-CONTAINING PROTEINS; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROMOTER REGIONS, GENETIC; RECTUM; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 84872676785     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.5.1917     Document Type: Article

References (25)

1. Asif R, Jean PJ (2004). CpG island methylation in gastroenterologic neoplasia: a maturing field. Gastroenterology, 127, 1578-88.
2. Claudia G, Erica L, Letizia L, et al (1997). A novel SH3-containing human gene family preferentially expressed in the central nervous system. Genomics, 41, 427-34.
3. Christopher GB, Andrew ET, Vardhman KR, Alexander PM, Stephan B (2010). Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus. BMC Med Genomics, 3, 33.
4. Christina T, Marianne E, Andrew F, et al (2010). Genome-wide DNA methylation analysis of archival formalin-fixed paraffin-embedded tissue using the Illumina Infinium HumanMethylation27 BeadChip. Methods, 52, 248-54.
5. Donkena KV, Mathias E, Dirk VdB, et al (2009). Hypermethylation of genes for diagnosis and risk stratification of prostate cancer. Cancer Invest, 27, 549-60.
6. Henan L, Xiaohuan G, Luning S, et al (2010). CMTM5-v1, a four-transmembrane protein, presents a secreted form released via a vesicle-mediated secretory pathway. BMB Rep, 43, 182-7.
7. Igor PP, Frederick AB(2009). DNA hypomethylation in the origin and pathogenesis of human diseases. Cell Mol Life Sci, 66, 2249-61.
8. Joseph FC, Michael CF, Dominic JS, et al (2000). Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet, 25, 132-8.
9. Katsuya S, Koshi M, Fumiaki T, et al (2008). Prognostic relevance of Tensin4 expression in human gastric cancer. Ann Surg Oncol, 15, 2606-13.
10. Khare S, Verma M (2012). Epigenetics of colon cancer. Methods Mol Biol, 863, 177-85.
11. Luning S, Yan C, Hong YL, et al (2007). CMTM5 exhibits tumor suppressor activities and is frequently silenced by methylation in carcinoma cell lines. Clin Cancer Res, 13, 5756-62.
12. Luning S, Xiaohuan G, Markus P, et al (2009). CMTM5-v1 induces apoptosis in cervical carcinoma cells. Biochem Biophys Res Commun, 379, 866-71.
13. Li LW, Yu XY, Yang Y, et al (2009). Expression of esophageal cancer related gene 4 (ECRG4), a novel tumor suppressor gene, in esophageal cancer and its inhibitory effect on the tumor growth in vitro and in vivo. Int J Cancer, 125, 1505-13.
14. Li L, Zhang C, Li X, Lu S, Zhou Y (2010). The candidate tumor suppressor gene ECRG4 inhibits cancer cells migration and invasion in esophageal carcinoma. J Exp Clin Canc Res, 29, 133.
15. Michael W, Jonathan JD, David W, et al (2005). Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet, 37, 853-62.
16. Manel E (2007). Cancer epigenomics: DNA methylomes and histone-modification maps. Nature, 8, 286-98.
17. Maria AH, Gerd PP (2010). Methods for genome-wide analysis of DNA methylation in intestinal tumors. Mutat Res, 693, 77-83.
18. Pei WA, Marie L, Natalia L, et al (2010). Comprehensive profiling of DNA methylation in colorectal cancer reveals subgroups with distinct clinicopathological and molecular features. BMC Cancer, 10, 227.
19. Su TN, Shogo H, Hitoshi T, et al (2007). Identification of a predictive gene expression signature of cervical lymph node metastasis in oral squamous cell carcinoma. Cancer Sci, 98, 740-6.
20. Silke G, Valeska F, Thilo T, et al (2009). ECRG4 is a candidate tumor suppressor gene frequently hypermethylated in colorectal carcinoma and glioma. BMC Cancer, 9, 447.
21. Tobias S, Siân J, Laura DW, et al (2006). The consensus coding sequences of human breast and colorectal cancers. Science, 314, 268-74.
22. Van dAI, Yu W, Suo L, et al (2010). Array-based DNA methylation profiling for breast cancer subtype discrimination. PloS One, 5, e12616.
23. Wang TP, Hsu SH, Feng HC, Huang RF (2012). Folate deprivation enhances invasiveness of human colon cancer cells mediated by activation of sonic hedgehog signaling through promoter hypomethylation and cross action with transcription nuclear factor-kappa B pathway. Carcinogenesis, Apr 26.
24. Xiaohuan G, Ting L, Yu W, et al (2009). CMTM5 induces apoptosis of pancreatic cancer cells and has synergistic effects with TNF-a. Biochem Biophys Res Commun, 387, 139-42.
25. Yoichiro M, Hideyuki I, Yoshiyuki K, et al (2007). Expression of ECRG4 is an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma. Oncol Rep, 18, 981-5.